Drug recall · April 15, 2020
Tetracycline HCL Capsules recall
Why: Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-018-01
- Lots / codes
Lot #s: G190609, G190610, G190611, Exp Jun 2022: L191027, L191028, Exp Nov 2022: K190953, K190952, Exp Oct 2022
- Quantity
- 17,524 bottles
- Company
- Avet Pharmaceuticals, Inc., East Brunswick, NJ
- Distribution
- Distributed Nationwide in the US
- Initiated
- March 23, 2020 · Voluntary: Firm initiated
- Classified
- April 27, 2020
- Reported
- April 15, 2020
- Ended
- August 23, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tetracycline
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.